Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
06/1998
06/17/1998EP0847275A1 Regulation of intracellular glucocorticoid concentrations
06/16/1998US5767293 Antitumor
06/16/1998US5767262 Isolated dna comprising sequence encoding smooth muscle cell lim polypeptide
06/16/1998US5767251 Polypeptides
06/16/1998US5767139 Skin disorders; alopecia; prostate cancer
06/16/1998US5767118 4-Heterocyclic peperidines promote release of growth hormone
06/16/1998US5767085 Peptide derivatives
06/16/1998US5766886 Modified antibody variable domains
06/11/1998WO1998024922A1 Insulin-like growth factor i (igf-i) expression system and methods of use
06/11/1998WO1998024807A2 Somatostatin antagonists
06/11/1998WO1998024802A2 Compound
06/11/1998WO1998024448A1 METHOD OF PREVENTING NEURODEGENERATION AND COGNITIVE DYSFUNCTION USING 17α-DIHYDROEQUILENIN
06/11/1998CA2272891A1 Method of preventing neurodegeneration and cognitive dysfunction using 17.alpha.-dihydroequilenin
06/10/1998EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
06/10/1998EP0845987A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
06/10/1998EP0845985A1 Non-steroidal sulfatase inhibitor compounds and their method of use
06/10/1998CN1184112A Inositolglycans having insulin-like action
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763398 Sprayable aqueous solution for drug delivery yields uniform plasma levels of the desmopressin peptide
06/09/1998US5763200 Inhibition of amylin release
06/04/1998WO1998023636A1 Heptapeptide oxytocin analogues
06/03/1998EP0845475A1 Inositolglycans with insular activity
06/03/1998CN1183726A Synthetic cryptophycins
06/03/1998CN1183723A Transdermal therapeutic system for administering testosterone
06/02/1998US5760068 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/02/1998US5760025 Administering testosterone 5a-reductase inhibitors
05/1998
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998CA2270407A1 Human kdel receptor
05/27/1998EP0843678A1 1,9-diazabicyclo 4.3.0]nona-3,8-diene derivatives
05/27/1998EP0587571B1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN
05/27/1998CN1182591A Improvement for prevention of mammary gland cancer or the prevention of mammary gland canner
05/27/1998CN1182590A Method for prevention of mammary gland cancer
05/27/1998CN1038510C Process for the synthesis of ergoline derivatives
05/26/1998US5756733 Vitamin D amide derivatives
05/22/1998WO1998021228A1 Tissue specific expression of retinoblastoma protein
05/22/1998WO1998020906A2 Treatment of diabetes with transcription factor gene
05/22/1998CA2271100A1 Treatment of diabetes with transcription factor gene
05/20/1998EP0842193A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
05/20/1998EP0842175A1 Imidazopyridine derivatives
05/20/1998EP0842148A1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
05/20/1998EP0841907A1 Use of agonists or antagonists of p 2? purinoceptors for the prevention of glutamate-evoked cytotoxicity
05/20/1998CN1182453A MPL Ligand analogs
05/19/1998US5753688 Antiinflammatory
05/19/1998US5753648 Tricyclic benzazepine vasopressin antagonists
05/14/1998WO1998019697A2 Novel pharmaceutical compositions
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998CA2270927A1 Novel pharmaceutical compositions
05/13/1998EP0840612A1 Inhibition of nmda receptor activity by pregnenolone sulfate derivatives
05/13/1998CN1038304C Method for prepn. of growth inhibiting compsn.
05/12/1998US5750531 Pyrimidine derivatives and processes for the preparation thereof
05/12/1998US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE
05/12/1998US5750391 Filariid nematode cysteine protease proteins
05/07/1998WO1998018779A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018778A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018777A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018776A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018775A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018774A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018773A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
05/07/1998WO1998018771A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018759A1 Vitamin d analogues
05/07/1998WO1998018449A1 Methods of preventing breast cancer
05/07/1998WO1998018430A2 P2y receptor antagonists
05/07/1998WO1998018325A1 Prophylaxis of breast cancer
05/07/1998WO1998007855A3 Secreted proteins and polynucleotides encoding them
05/07/1998CA2270113A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270111A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270056A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270055A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269974A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269973A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269970A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269936A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2241687A1 P2y receptor antagonists
05/06/1998EP0839533A1 Methods of preventing breast cancer by the administration of Raloxifene
05/06/1998EP0839532A1 Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene
05/06/1998EP0839137A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
05/06/1998EP0839046A1 Tnf receptor and steroid hormone in a combined therapy
05/06/1998EP0839039A1 Paroxetine controlled release compositions
05/06/1998EP0438519B1 Therapeutic peptides
05/05/1998US5747642 Monomeric insulin analog formulations
04/1998
04/30/1998CA2219377A1 Improvements in or relating to the prophylaxis of breast cancer
04/29/1998EP0838461A2 Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity
04/28/1998US5744448 Human follicle stimulating hormone receptor
04/23/1998WO1998016544A1 8(9)-dehydroestradiol derivatives
04/23/1998WO1998016527A1 Benzoxepine derivatives which promote release of growth hormone
04/23/1998WO1998016205A2 Stable glassy state powder formulations
04/23/1998CA2268330A1 8(9)-dehydroestradiol derivatives
04/22/1998EP0836380A1 Fgf9 as a specific ligand for fgfr3
04/21/1998US5741795 Administering to treat hyperandrogenic conditions, such as, acne vulgaris
04/16/1998WO1998015543A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
04/16/1998CA2267154A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
04/15/1998EP0835878A1 Benzo (b) thiophene compounds, intermediates, formulations, and methods
04/15/1998EP0835872A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods
04/15/1998EP0835871A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods
04/15/1998EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods
04/15/1998EP0835263A2 Somatostatin peptides
04/15/1998EP0835262A1 Method for the treatment of corticosteroid induced osteopenia
1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 290